Methods
This study includes a secondary analysis of data collected as part of a
quality improvement (QI) initiative to assess adherence barriers within
clinical care. Collection and retrospective analysis of anonymized data
were approved by the Institutional Review Board. Participants in the
larger QI initiative included caregivers (of patients ages 0-18 years),
children, and AYAs diagnosed with VTE who were followed for therapeutic
anticoagulation in the Hematology clinic at Cincinnati Children’s
Hospital Medical Center (May-November 2019).